Connecticut General Statutes
Chapter 400j - Pharmacy
Section 20-592. - Licensure of individual who is a licensed pharmacist in another state or jurisdiction.

Any individual who is a licensed pharmacist in any other state of the United States, the District of Columbia, the Commonwealth of Puerto Rico or any territory or insular possession subject to the jurisdiction of the United States, may be licensed to practice pharmacy in this state in accordance with regulations adopted under sections 20-570 to 20-630, inclusive, in accordance with chapter 54.

(P.A. 95-264, S. 17; P.A. 99-175, S. 20.)
History: P.A. 99-175 amended Subsec. (a) to delete subsection designation and reference to Subsec. (b) and replace reference to Sec. 20-625 with reference to Sec. 20-630 and deleted Subsec. (b).

<< Previous
Next >>

Structure Connecticut General Statutes

Connecticut General Statutes

Title 20 - Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards

Chapter 400j - Pharmacy

Section 20-570. - Short title: Pharmacy Practice Act.

Section 20-571. (Formerly Sec. 20-184a). - Definitions.

Section 20-572. (Formerly Sec. 20-163). - Commission of Pharmacy. Appointment and term of members.

Section 20-573. (Formerly Sec. 20-165). - Meetings of commission. Records.

Section 20-574. (Formerly Sec. 20-164a). - Supervision by Commissioner of Consumer Protection.

Section 20-575. - Powers and responsibilities.

Section 20-576. (Formerly Sec. 20-164). - Regulations.

Section 20-576a. - Acceptance and disposal of unused prescription drugs at pharmacies. Regulations.

Section 20-577. (Formerly Sec. 20-179). - Employment of inspectors by Commissioner of Consumer Protection; duties. Inspection of correctional, juvenile training and care-giving institutions, dispensing outpatient facilities, institutional and retail...

Section 20-578. (Formerly Sec. 21a-306). - Information not to be disclosed. Exception.

Section 20-579. (Formerly Sec. 20-175). - Causes for suspension, revocation, refusal to issue or renew or the placing of conditions on licenses, temporary permits and registrations and for assessment of civil penalty.

Section 20-580. (Formerly Sec. 20-167). - Revocation or suspension of nonlegend drug permit.

Section 20-581. (Formerly Sec. 20-185). - Penalty for violation of Pharmacy Practice Act. Exception.

Section 20-582. (Formerly Sec. 20-176). - Appeals of decisions of Commission of Pharmacy.

Section 20-583. - Where appeals returnable.

Section 20-590. (Formerly Sec. 20-170). - Issuance of license or temporary permit to practice pharmacy; requirements.

Section 20-591. - Graduates of foreign pharmacy schools. Regulations.

Section 20-592. - Licensure of individual who is a licensed pharmacist in another state or jurisdiction.

Section 20-593. (Formerly Sec. 20-172). - Pharmacist license certificate; expiration; renewal; fee; display document.

Section 20-594. (Formerly Sec. 20-168). - Pharmacy license; application; information required; issuance or renewal of license; expiration. Transfer of pharmacy to new location. Report re administrative or legal action.

Section 20-595. (Formerly Sec. 20-168a). - Pharmacy licenses held by corporations. Notice of change in officers or directors.

Section 20-596. (Formerly Sec. 20-168b). - Ownership of pharmacies by prescribing practitioners.

Section 20-597. (Formerly Sec. 20-169). - Pharmacy to be supervised and managed by pharmacist. Regulations re prescription department. Change in management, ownership or name of pharmacy.

Section 20-598. (Formerly Sec. 20-177). - Registration of pharmacy interns.

Section 20-598a. - Registration and certification of pharmacy technicians.

Section 20-599. (Formerly Sec. 20-174a). - Continuing education: Definitions.

Section 20-600. (Formerly Sec. 20-174b). - Continuing education: Requirements; renewal of licenses; regulations.

Section 20-601. - Fees.

Section 20-605. - Practice of pharmacy without license or temporary permit prohibited.

Section 20-606. (Formerly Sec. 20-178). - Use of the title “pharmacist”.

Section 20-607. (Formerly Sec. 20-173). - Certificate of license, temporary permit or registration to be available for inspection.

Section 20-608. (Formerly Sec. 20-174). - Use of certificate of license, temporary permit or display document by unlicensed person prohibited.

Section 20-609. (Formerly Sec. 20-184). - Pharmacy license to be posted. Business which is not a pharmacy prohibited from using words, displays or symbols indicating it is a pharmacy; exemption.

Section 20-609a. - Use of electronic technology or telepharmacy by hospital. Quality assurance evaluations.

Section 20-610. (Formerly Sec. 20-166). - Dispensing or retail sale of legend drugs, legend devices and certain other drugs by other than pharmacies and hospitals, prohibited.

Section 20-611. (Formerly Sec. 20-175b). - Advertising legend drug prices.

Section 20-612. - Only pharmacy may accept prescription for dispensing.

Section 20-612a. - Confirmation of identification prior to release of controlled substance. Exceptions.

Section 20-613. (Formerly Sec. 21a-308). - Dispensing of drug or legend device pursuant to prescription only; exceptions. Emergency dispensing of drug or device in care-giving, correctional or juvenile training institutions; regulations. Pharmacy tec...

Section 20-613a. - Requests for controlled substance issued on results of answers to electronic questionnaire. Regulations.

Section 20-614. (Formerly Sec. 20-184b). - Prescriptions: Form and content. Offer to consult with pharmacist. Electronic data intermediaries.

Section 20-615. (Formerly Sec. 20-184c). - Prescriptions: Pharmacy to assign serial number and maintain records. Transfer of records to another pharmacy.

Section 20-616. (Formerly Sec. 20-184d). - Prescription refills and transfers. Thirty-day supply of diabetes drugs and devices. Notice to prescribing practitioner. Payment. Referral to federally-qualified health center.

Section 20-616a. - Prescription refills for quantity of drug greater than initial quantity prescribed. Conditions.

Section 20-617. (Formerly Sec. 20-184e). - Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions.

Section 20-617a. - Flavoring agent added to prescription product.

Section 20-618. (Formerly Sec. 21a-107). - Repackaged drugs not considered misbranded, when.

Section 20-619. (Formerly Sec. 20-185a). - Substitution of generic drugs and biological products. Definitions. Interchangeable biological products. Prescribing practitioners. Pharmacy signs. Dispensing. Records. Regulations.

Section 20-619a. - Biological product prescribing. Prescribing practitioner discussion with patient or representative. Documentation. Patient request to sign for delivery.

Section 20-620. (Formerly Sec. 20-185g). - Pharmacist's duties towards Medicaid recipients: To obtain, record and maintain pertinent patient information about the recipient; to undertake a review of the drugs previously dispensed to the recipient and...

Section 20-621. (Formerly Sec. 20-185h). - Relabeling and dispensing of parenteral medication in hospital and nursing home pharmacies: When allowed.

Section 20-621a. - Use of automated prescription dispensing machine in long-term care pharmacies authorized. Regulations.

Section 20-622. (Formerly Sec. 20-180a). - Licensed practitioners may authorize medication to be dispensed from a hospital emergency room.

Section 20-623. - Sale of nonlegend drugs. Labels, packaging and contents. Penalty.

Section 20-624. - Permit to sell nonlegend drugs.

Section 20-625. - Nonlegend veterinary drugs.

Section 20-626. - Confidentiality of pharmacy records.

Section 20-627. - Nonresident pharmacy. Definitions. Certificate of registration. Requirements.

Section 20-628. - Shipping, mailing or delivering legend devices or drugs.

Section 20-629. - Denial, revocation or suspension of nonresident pharmacy certificate of registration. Referral by commission.

Section 20-630. - Advertising.

Section 20-631. - Collaborative drug therapy management agreements between pharmacists and physicians or advanced practice registered nurses. Scope. Pharmacist competency requirements. Regulations.

Section 20-631a. - Collaborative drug management agreements between pharmacists employed by community pharmacies and one or more physicians or advanced practice registered nurses. Pilot program.

Section 20-631b. - Collaborative drug therapy management agreements entered into prior to October 1, 2010.

Section 20-632. - Regulatory action report re disciplinary action against persons with controlled substance registrations and sanctions against pharmacists or pharmacies.

Section 20-633. - Administration of vaccines by licensed pharmacists. Regulations.

Section 20-633a. - Pharmacy rewards program. Plain language summary. Violation.

Section 20-633b. - Sterile compounding pharmacies. Requirements. Regulations.

Section 20-633c. - Prescribing of opioid antagonists by licensed pharmacists. Regulations.

Section 20-633d. - Medical protocol standing order for dispensing of opioid antagonists by licensed pharmacists. Regulations.

Section 20-633e. - Pharmacy and institutional pharmacy perpetual inventory of Schedule II controlled substances. Regulations.

Section 20-633i. - Issuance of prescriptions for epinephrine auto injectors by pharmacists.

Section 20-635. - Prescription error reporting. Definitions. Informational signs and statements. Regulations. Nondisclosure of records.

Section 20-636. - Sign re storage and disposal of prescription drugs.